Pluristem Therapeutics (PSTI) Selects Rotator Cuff Repair As New Orthopedic Indication
6/25/2014 8:12:32 AM
HAIFA, Israel, June 25, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, today announced it has selected rotator cuff repair as the second indication in its orthopedic clinical program. The Company's PLacental eXpanded (PLX) cells offer potential as the first off-the-shelf cell therapy product for muscle and tendon regeneration that can be used to enhance repair after rotator cuff surgery. There are currently no FDA-approved therapies using engineered cells for the treatment of rotator cuff injuries.
Help employers find you! Check out all the jobs and post your resume.
comments powered by